BE PHARMACEUTICALS AG recalls
Every recall we track for BE PHARMACEUTICALS AG — 2 in all, from 2023–2024 — plus the complaints and injury reports the public filed about them. 1 is rated “stop using now”.
Recalls per year, by danger level
2 recalls since 2017.
All FDA recall records for BE PHARMACEUTICALS AG since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 1 |
| 2024 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled BE PHARMACEUTICALS AG product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All BE PHARMACEUTICALS AG recalls
2 shown- Lower riskDrug
BE PHARMACEUTICALS AG recalls Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution
BE Pharmaceuticals recalls Fosaprepitant 150mg vials due to potential sterility issues after reconstitution. This could lead to infections if used improperly. Check your vial's lot number and contact the company for details.
BE PharmaceuticalsJan 10, 2024 - Stop using nowDrug
BE PHARMACEUTICALS AG recalls Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose
BE Pharmaceuticals recalls Pantoprazole Sodium 40mg injection vials due to potential powder discoloration from cracks, risking contamination. Affected lots manufactured in India with specific expiration dates.
BE PharmaceuticalsSep 5, 2023
BE PHARMACEUTICALS AG recall questions
How many recalls has BE PHARMACEUTICALS AG had?
2 recalls from BE PHARMACEUTICALS AG are on record with U.S. safety agencies, from 2023–2024.
What is the most recent BE PHARMACEUTICALS AG recall?
BE PHARMACEUTICALS AG recalls Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution, dated Jan 10, 2024. Every BE PHARMACEUTICALS AG recall is listed on this page, newest first.
What should I do if I have a recalled BE PHARMACEUTICALS AG product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new BE PHARMACEUTICALS AG recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.